1

European Technology Platform for European Technology Platform for Global Animal Health (ETPGAH)Global Animal Health (ETPGAH)

Mirror Groups

Meeting

Brussels22 September 2009

Jim Scudamore

2

Mirror Group MeetingSources of Finance

Outline of the Presentation.

1. Introduction

2. Framework 7

3. COST

4. EMIDA ERANET

5. Other

6. Conclusions

3

ETP Global Animal HealthThe Vision

Published August 2005

To facilitate and accelerate the development and distribution of

the most effective tools for controlling animal diseases of

major importance to Europe and the rest of the world, thereby

improving human and animal health, food safety and quality, animal welfare, and market access, contributing to achieving the

Millennium Development Goals.”

4

ETP Global Animal HealthThe Process

Stakeholders, led by industry, come together

to agree on a common

vision for the technology

Stakeholders, define a

Strategic Research Agenda setting the necessary

mid- to longterm objectives

Stakeholders, implement the

Strategic ResearchAgenda with the mobilisation of

significant humanand financial

resources

Vision paper:

“EU TP Global Animal Health”

Launch Dec 2004 Final version August 2005

Strategic Research Agenda:

Published May 2006

Action Plan:

Published July 2007

DISCONTOOL2008

Examples from FP7

EMIDA2008

ICONZ2009

5

ETP Global Animal HealthAction plan

Published July 2007

The Action Plan is intended to be a flexible working document, subject to regular review and up dating by the ETPGAH to ensure that the SRA is on target and that the recommendations are being delivered.

6

ETP Global Animal HealthAction Plan

How will the action plan be used.

Template

Guidance

Liaison

Lobbying

Funding

7

ETP Global Animal HealthFunding

Sources of funding for the proposalsEC Programs (e.g. FP7, COST, DGs)• Close consultation with EC, MSs, EP representativesNational research programs- EMIDA• Providing opportunities to better align and coordinate

national programs. (EMIDA ERA-Net), SCARPublic/private research partnerships• Exploring areas of strategic importance in which ambitious

initiatives can be takenCharities and private non-profit foundations .

All these funding bodies have their own agendas/priorities that are set independently of each other)

8

Mirror Group MeetingSources of Finance

Outline of the Presentation.

1. Introduction

2. Framework 7

3. COST

4. EMIDA ERANET

5. Other

6. Conclusions

9

Cooperation – Collaborative research €32.342b (€1.944)

Cooperation – Collaborative research €32.342b (€1.944)

People – Human Potential €4.728bPeople – Human Potential €4.728b

Ideas – Frontier Research €7.460bIdeas – Frontier Research €7.460b

Capacities – Research Capacity €4.243bCapacities – Research Capacity €4.243b

EC Funding : Framework 7 Programme 2007 to 2013

Cooperation is 64% of budget of FP 7 budget of €50.524 billionFood, Agriculture & Biotech - €1.944b

10

Collaborative research(Collaborative projects; Networks of Excellence; Coordination/support actions)

Collaborative research(Collaborative projects; Networks of Excellence; Coordination/support actions)

Joint Technology InitiativesJoint Technology Initiatives

Coordination of non-Community research programmes(ERA-NET; ERA-NET+; Article 169)

Coordination of non-Community research programmes(ERA-NET; ERA-NET+; Article 169)

International CooperationInternational Cooperation

Cooperation – Collaborative researchCooperation – Collaborative research

Small collaborative projects (“small or medium-scale focused research actions”) are projects with a requested Commission contribution up to € 3 million

Large collaborative projects (“large-scale integrating projects”) and Networks of Excellence between € 3 million and € 6 million

Coordination and Support Actions (CSA) up to € 1 million

11

Calls madeCall FP7-KBBE-2007-1:

Publication Date: 22/12/2006: Deadline: 02/5/07

ERA Net, discontools, BTb, ASF, RVF, WNF, CCF

FP7- KBBE-2007-2A:

Publication Date: 15/6/2007, Deadlines: 11/9/07 : stage 2 19/2/08 - Stage 2 (only for proposals retained at stage 1

Wildlife, ICONZ, zoonoses

FP7- KBBE-2008-2B:

Publication Date: 30/11/ 2007: Deadline: 26/2/ 2008.

FMD, CSF

FP7- KBBE-2009-3:

Publication Date: 03/9/2008 : Deadline: 15/1/ 2009

PRRS, Orboviruses, Tick borne diseases, campylobacter

FP7-KBBE-2010-4

Publication Date 30/7/2009 Deadline 14/1/2010

Swine influenza, Parasites,welfare

Cooperation – Collaborative researchCooperation – Collaborative research

12

Activity 2.1: Sustainable production and management of biological resources from land,forest and aquatic environments

Area Topics called Funding Schemes

2.1.3–

KBBE.2010.1.3-01: Development of vaccines and improvement of detection systems to control helminth parasite infections of livestock and reservoirs

SICA (Latin America and/or Asia and/or African Mediterranean Partner Countries and/or African ACP) Collaborative Project (large- scale integrating project) for Specific Cooperation Actions Dedicated to International Cooperation Max. EC contribution/proposal: EUR 9 000 000

2.1.3 KBBE.2010.1.3-02: Promoting coordination and cooperation at international level of research programmes in the area of animal health, in particular infectious diseasesincluding zoonoses -

Mandatory ICPC (Latin America and Asia) Coordination and Support Action (coordinating action) Max. EC contribution/proposal:EUR 1 000 000

2.1.3 KBBE.2010.1.3-03: Development and integration of animal based welfare indicators in livestock species

Collaborative Project (large scale integrating project) Max. EC contribution/proposal: EUR 4 500 000

2.1.3 KBBE.2010.1.3-04: Improving integration in farm animal welfare research in an enlarged Europe

Coordination and Support Action (coordinating action) Max. EC contribution/proposal: EUR 1 000 000

KBBE.2010.1.3-05: Swine influenza surveillance network Coordination and support action (coordinating action) Max. EC contribution per proposal: EUR 1 000 000 Maximum one proposal can be selected.

KBBE.2010.1.3-06: Pathogenesis and transmission ofinfluenza in pigs (CP-IP)

Collaborative project (large scale integrating project32) Max. EC contribution per proposal: EUR 5 000 000 Maximum one proposal can be selected

FP7 KBBE-2010-4

13

Group 1 Epizootic diseases and diseases for surveillance

Vaccine Diagnostic Pharmaceutical

Control Strategy Capacitybuilding

African Horse Sickness  FP7  FP7    FP7  FP7 FP7

African Swine Fever   ASFRISK     ASFRISK  ASFRISK ASFRISK

Avian Influenza  FP6 FP6    FP6  FP6  FP6

Bluetongue  FP6/7   FP6/7     FP6/7   FP6/7 FP6/7

Contagious Bovine Pleuro Pneumonia

         

Classical Swine Fever  CSFV GoDIVA

  CSFV GoDIVA

    CSFV GoDIVA

  CSFV GoDIVA

CSFV GoDIVA

Foot & Mouth Disease  Discovac  Discovac      Discovac   Discovac  Discovac

Peste des Petits Ruminants

         

Rift Valley Fever    ARBOZOONET

    ARBOZOONET

   ARBOZOONET

Ruminant Pox Virus infection

         

Swine Vesicular Disease

         

West-Nile Virus    ARBOZOONET

    ARBOZOONET

   ARBOZOONET

FP7 projects contributing to research

14

Group 2 : Zoonoses and food-borne diseases

Vaccine Diagnostic Pharmaceutical Control Strategy Capacity building

Anthrax

Nipah virus infection

Bovine Tuberculosis ICONZTB_STEP

ICONZTB_STEP

ICONZTB_STEP

ICONZTB_STEP

BrucellosisICONZ ICONZ ICONZ ICONZ

Chlamydia

Cryptosporidium

CysticercosisICONZ ICONZ ICONZ ICONZ

EchinococcosisICONZ ICONZ ICONZ ICONZ

Food-borne bacterial: Salmonella E. Coli Campylobacter

FP7 FP7 FP7

Food-borne viral (Hepatitis E Virus

LeishmaniasisICONZ ICONZ ICONZ ICONZ

Leptospirosis

Q Fever

RabiesICONZ ICONZ ICONZ ICONZ

TrypanosomiasisICONZ ICONZ ICONZ ICONZ ICONZ

Transmissible Spongiform Encephalopathies

15

Group 3: Major food-producing animal disease complexes

Vaccine Diagnostic Pharmaceutical Control Strategy Capacity building

Parasitic gastro-intestinal diseasesLiver FlukeCoccidiosisNematodes FP7/10 FP7/10 FP7/10 FP7/10 FP/10 FP7/10

Paratuberculosis (Johne’s)

Mastitis : Staph.aureus mastitis Environmental/Streptococcal mastitisSmall ruminant mastitis

Respiratory – SwinePRRS – CG3 + HNPCV IISIVA. pleuropneumoniaMycoplasma

FP7/09 FP7/09 FP7 2009 FP7/09 FP7/09 FP7/09

Respiratory – BovineBVDVBRSVBHV-I (IBR)Mycoplasma

FP6 and FP7 projects contributing to research

16

Cooperation – Collaborative research €32.342b (€1.944)

Cooperation – Collaborative research €32.342b (€1.944)

People – Human Potential €4.728bPeople – Human Potential €4.728b

Ideas – Frontier Research €7.460bIdeas – Frontier Research €7.460b

Capacities – Research Capacity €4.243bCapacities – Research Capacity €4.243b

EC Funding : Framework 7 Programme 2007 to 2013 :

Cooperation is 64% of budget of FP 7 budget of €50.524 billionFood, Agriculture & Biotech - €1.944b

17

Capacities – Research CapacityCapacities – Research Capacity

2. Research for the benefit of SMEs2. Research for the benefit of SMEs

3. Regions of Knowledge3. Regions of Knowledge

4. Research Potential4. Research Potential

5. Science in Society5. Science in Society

1. Research Infrastructures

6. Activities of International Cooperation6. Activities of International Cooperation

18

Mirror Group MeetingSources of Finance

Outline of the Presentation.

1. Introduction

2. Framework 7

3. COST

4. EMIDA ERANET

5. Other

6. Conclusions

19

EC Funding : COST Programme

• COST – together with EUREKA and the EU framework programmes – is one of the three pillars of joint European research initiatives. These three complementary structures have differing areas of research.

20

21

22

23

24

25

Mirror Group MeetingSources of Finance

Outline of the Presentation.

1. Introduction

2. Framework 7

3. COST

4. EMIDA ERANET

5. Other

6. Conclusions

26

EC Funding : Framework 7 Programme 2007 to 2013 :

• The ERA-NET scheme was introduced under FP6 to support the networking of research funding organisations (programme owners and managers e.g. government ministries and research councils) to develop and strengthen the coordination of national research programmes.

• KBBE-2007-1-3-02: Coordination of European research in the area of animal health, including emerging threats, infectious diseases and surveillance. ERA-Net (SRA 13,35,37,47) (1m€) 3 years 1/4/08

27

Member State Funding:

EMIDA ERA-NET• Coordination of European research in the

area of animal health, including emerging threats, infectious diseases and surveillance

• 26 partners in 19 countries and four associated partners

• Combined research budget in the region of 270 million Euros

28

29

Aims of EMIDA

The overall aim of the Animal Health ERA-NET is to build on and accelerate the work of the SCAR CWG in developing a durable focused network of national research funders in Member and Associated States of the EU for the purpose of sharing information, coordinating activities and working towards a common research agenda and mutual research funding activities in the field of animal health.

30

Scope of EMIDA

The scope of the project will include emerging and major infectious diseases of production animals, including fish and bees and including those conditions which pose a threat to human health but excluding food safety issues relating to livestock products and diseases of wildlife, except where they act as a reservoir of infection for humans and animals.

31

32

Transnational Calls from EMIDA • Vectorborne diseases - Development of

underpinning knowledge and tools for early warning, detection & monitoring and novel control strategies

• Zoonoses and antimicrobial resistance, excluding microbial safety of products - Development of underpinning knowledge and tools for early warning, detection & monitoring and novel control strategies

• Major infectious diseases affecting production Development of underpinning knowledge and tools for early warning, detection & monitoring and novel control strategies, including genetics of resistance

• Aquaculture - Development of underpinning knowledge and tools for early warning, detection & monitoring and novel control strategies, particularly vaccine-based approaches

33

Transnational Calls from EMIDA

• Pre-announcement flyer www.EMIDA-ERA.NET

• Formal Announcement 21 July• Call opens 7 September• Pre-proposal Submission deadline

16 November• Invitation for full proposals 23 December• Deadline for full proposals 1 March• Funding decisions June 2010

34

Mirror Group MeetingSources of Finance

Outline of the Presentation.

1. Introduction

2. Framework 7

3. COST

4. EMIDA ERANET

5. Other

6. Conclusions

35

Mirror Group MeetingSources of Finance

Outline of the Presentation.

1. Introduction

2. Framework 7

3. COST

4. EMIDA ERANET

5. Other

6. Conclusions

36

Conclusions.

To be successful any proposals must:-

• Reinforce leadership at international level, increase international cooperation

• Early involvement of industry, SMEs

• Contribute to the– EU Animal Health Strategy– Development policy and MDGs– Action Plan ETPGAH

37

Mirror groups

38

THANK YOU